Application of immunocompetence assays for defining immunosuppression.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D002273:Carcinogens; D003520:Cyclophosphamide / Q000494:pharmacology*; D004785:Environmental Pollutants / Q000633:toxicity; D006462:Hemolytic Plaque Technique; D006846:Hydrocarbons, Halogenated / Q000494:pharmacology*; D007109:Immunity / Q000187:drug effects*; D007111:Immunity, Cellular / Q000187:drug effects; D007166:Immunosuppressive Agents; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D008722:Methods; D008748:Methylcholanthrene; D051379:Mice; D008807:Mice, Inbred BALB C; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000276:immunology; D011078:Polychlorinated Biphenyls / Q000494:pharmacology; D012513:Sarcoma, Experimental / Q000139:chemically induced / Q000276:immunology; D013154:Spleen / Q000187:drug effects / Q000276:immunology
D002273:Carcinogens; D004785:Environmental Pollutants; D006846:Hydrocarbons, Halogenated; D007166:Immunosuppressive Agents; D008748:Methylcholanthrene; D003520:Cyclophosphamide; D011078:Polychlorinated Biphenyls